Chlordiazepoxide
| Chlordiazepoxide | |
|---|---|
| Salts [] | |
|---|---|
| Chlordiazepoxide maleate | |
| Chlordiazepoxide hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 299.75 g/mol [1] |
| Melting point | 236-236.5 [1] |
| Solubility | 2000 mg/L [1] |
| Predicted LogP | 2.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H14ClN3O |
| IUPAC name | 7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine |
| SMILES | CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O |
| InChI | InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3 |
| InChIKey | BUCORZSTKDOEKQ-UHFFFAOYSA-N |
| CAS number | 58-25-3 |
| UNII | 6RZ6XEZ3CR |
| PubChem CID | 2712 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 5–30 hours (Active metabolite desmethyldiazepam 36–200 hours; other active metabolites include oxazepam) |
| Metabolism | Liver |
| Excretion | Kidney |
| Routes of administration | By mouth, intramuscular |
| Dependence liability | High[3] |
| Addiction liability | Moderate |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - Oral: 537 mg/kg [1] |
Chlordiazepoxide (also known as Methaminodiazepoxide, Librelease, Libritabs, Elenium, Librium, Chlozepid, Clopoxide, Clordiazepoxido, Radepur or Lygen) is a depressant substance of the benzylamine and benzodiazepine class.
Chemistry
Salts []
Stereochemistry []
Chlordiazepoxide is achiral.
Druglikeness
Lipinski's rule of five
Chlordiazepoxide matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Chlordiazepoxide binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor. BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| GABRA1 | shared target | 62 |
|---|---|---|
| GABRA2 | shared target | 58 |
| GABRA3 | shared target | 58 |
| GABRA4 | shared target | 58 |
| GABRA5 | shared target | 58 |
| GABRA6 | shared target | 58 |
| GABRB1 | shared target | 58 |
| GABRB2 | shared target | 58 |
| GABRB3 | shared target | 58 |
| GABRD | shared target | 58 |
| GABRE | shared target | 58 |
| GABRG1 | shared target | 58 |
| GABRG2 | shared target | 58 |
| GABRG3 | shared target | 58 |
| GABRP | shared target | 58 |
| GABRQ | shared target | 58 |
Medical side effects []
20 side effects listed on drug labels in SIDER 4.1 (chlordiazepoxide).
- Agranulocytosis
- Ataxia
- Confusional state
- Feeling abnormal
- Constipation
- Libido decreased
- Disturbance in sexual arousal
- Somnolence
- Oedema
- Blood disorder
- Jaundice
- Nausea
- Dizziness
- Shock
- Syncope
- Loss of consciousness
- Hepatic function abnormal
- Menstruation irregular
- Extrapyramidal disorder
- Rash
Indications
- Alcoholism
- Anxiety
- Anxiety disorder
- Apprehension
- Tension
- Withdrawal symptom
Legal status []
- Australia: Chlordiazepoxide is a Schedule 4.
- Brazil: Chlordiazepoxide is a B1.[4]
- Canada: Chlordiazepoxide is a Schedule IV.
- United States: Chlordiazepoxide is a Schedule IV under the "Controlled Substances Act".
- Germany: Chlordiazepoxide is Prescription only/Anlage III.
- United Kingdom: Chlordiazepoxide is a Class C under the "Misuse of Drugs Act 1971".
- Other: Chlordiazepoxide is a SE: Förteckning IV, In general: ℞ (Prescription only).[5]
External links []
- Chlordiazepoxide (Wikipedia)
- Chlordiazepoxide (PubChem)
- Chlordiazepoxide (Wikidata)
- Chlordiazepoxide (DrugBank)
- Chlordiazepoxide (ChEMBL)
- Chlordiazepoxide (ChEBI)
- Chlordiazepoxide (Common Chemistry)
- Chlordiazepoxide (KEGG)
- Chlordiazepoxide (EPA DSSTox)
- Chlordiazepoxide (Effect Index)
- Chlordiazepoxide (UNII)
- Chlordiazepoxide (SIDER)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2712, Chlordiazepoxide. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2712
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Chlordiazepoxide. UNII: 6RZ6XEZ3CR. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6RZ6XEZ3CR
Edmunds M, Mayhew M. Pharmacology for the Primary Care Provider. Mosby. 2013. https://books.google.com/books?id=8FwdEsvnw8oC&pg=PA545
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Klordiazepoxid. Läkemedelsverket.se. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4pobuu91snvert1/klordiazepoxid
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 17:59:59 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 17:59:55 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 17:59:55 |
| gsrs | ok | 2026-11-20 17:59:57 |
| hmdb | missing (no HMDB id) | 2026-11-20 17:59:55 |
| kegg | ok | 2026-11-20 17:59:59 |
| pubchem | ok | 2026-11-20 17:59:55 |
| missing (no r/tripreports posts mention it) | 2026-11-20 17:59:55 | |
| sider | ok | 2026-11-20 17:59:55 |
| structure | ok | 2026-11-20 17:59:55 |
| wikipedia | ok | 2026-11-20 17:59:55 |